Nonsteroidal anti-inflammatory drugs and risk of lung cancer.

PubWeight™: 1.12‹?› | Rank: Top 10%

🔗 View Article (PMID 17205530)

Published in Int J Cancer on April 01, 2007

Authors

Sonia Hernández-Díaz1, Luis A García Rodríguez

Author Affiliations

1: Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA. shernan@hsph.harvard.edu

Articles citing this

Regular adult aspirin use decreases the risk of non-small cell lung cancer among women. Cancer Epidemiol Biomarkers Prev (2008) 1.17

Aspirin and lung cancer risk in a cohort study of women: dosage, duration and latency. Br J Cancer (2007) 1.04

Use of NSAIDs, smoking and lung cancer risk. Br J Cancer (2007) 0.95

Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case-control studies. Br J Cancer (2011) 0.94

Association of smoking with amyotrophic lateral sclerosis risk and survival in men and women: a prospective study. BMC Neurol (2010) 0.93

Aspirin and NSAID use and lung cancer risk: a pooled analysis in the International Lung Cancer Consortium (ILCCO). Cancer Causes Control (2011) 0.89

Prediagnostic nonsteroidal anti-inflammatory drug use and lung cancer survival in the VITAL study. J Thorac Oncol (2012) 0.85

Aspirin and non-steroidal anti-inflammatory drug use and the risk of upper aerodigestive tract cancer. Br J Cancer (2014) 0.84

Non-steroidal anti-inflammatory drugs use is associated with reduced risk of inflammation-associated cancers: NIH-AARP study. PLoS One (2014) 0.82

Use of glucosamine and chondroitin and lung cancer risk in the VITamins And Lifestyle (VITAL) cohort. Cancer Causes Control (2011) 0.82

A novel sulindac derivative lacking cyclooxygenase-inhibitory activities suppresses carcinogenesis in the transgenic adenocarcinoma of mouse prostate model. Cancer Prev Res (Phila) (2010) 0.80

Design, synthesis and biological evaluation of new 5,5-diarylhydantoin derivatives as selective cyclooxygenase-2 inhibitors. Sci Pharm (2011) 0.77

Molecular docking analysis of known flavonoids as duel COX-2 inhibitors in the context of cancer. Bioinformation (2015) 0.75

Aspirin use and lung cancer risk: a possible relationship? Evidence from an updated meta-analysis. PLoS One (2015) 0.75

Use of azithromycin and risk of ventricular arrhythmia. CMAJ (2017) 0.75

Association of nonsteroidal anti-inflammatory drugs and aspirin use and the risk of head and neck cancers: a meta-analysis of observational studies. Oncotarget (2016) 0.75

Cohort restriction based on prior enrollment: Examining potential biases in estimating cancer and mortality risk. Obs Stud (2016) 0.75

Articles by these authors

Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med (2005) 4.57

The birth weight "paradox" uncovered? Am J Epidemiol (2006) 4.38

Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis. BMC Cancer (2003) 1.98

Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med (2007) 1.95

Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br J Clin Pharmacol (2004) 1.95

Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction. Basic Clin Pharmacol Toxicol (2006) 1.90

Confounding adjustment via a semi-automated high-dimensional propensity score algorithm: an application to electronic medical records. Pharmacoepidemiol Drug Saf (2011) 1.85

Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications. BMC Med (2006) 1.62

Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis Rheum (2010) 1.61

Hormone therapy and cerebrovascular events: a population-based nested case-control study. Menopause (2006) 1.43

Cardiovascular and upper gastrointestinal bleeding consequences of low-dose acetylsalicylic acid discontinuation. Thromb Haemost (2013) 1.43

Incidence and risk factors for atrial fibrillation in patients with newly diagnosed heart failure. J Cardiovasc Med (Hagerstown) (2016) 1.38

Positive predictive value of computerized medical records for uncomplicated and complicated upper gastrointestinal ulcer. Pharmacoepidemiol Drug Saf (2009) 1.30

Contemporary epidemiology of gout in the UK general population. Arthritis Res Ther (2011) 1.26

Morbidity associated with sleep disorders in primary care: a longitudinal cohort study. Prim Care Companion J Clin Psychiatry (2007) 1.23

Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease. Neurology (2006) 1.21

Statins and risk of diabetes: an analysis of electronic medical records to evaluate possible bias due to differential survival. Diabetes Care (2012) 1.12

Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.11

Respiratory medications and the risk of cardiac arrhythmias. Epidemiology (2005) 1.05

Acid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapy. Gastroenterology (2011) 1.03

Breast cancer risk among users of antidepressant medications. Epidemiology (2005) 0.99

Androgen deprivation therapy and the risk of coronary heart disease and heart failure in patients with prostate cancer: a nested case-control study in UK primary care. Drug Saf (2011) 0.94

Cancer incidence in a general population of asthma patients. Pharmacoepidemiol Drug Saf (2006) 0.90

Gallbladder disease in the general population: association with cardiovascular morbidity and therapy. Pharmacoepidemiol Drug Saf (2007) 0.87

Controversies in COX-2 selective inhibition. J Rheumatol (2002) 0.86

Systematic review of peptic ulcer disease incidence rates: do studies without validation provide reliable estimates? Pharmacoepidemiol Drug Saf (2011) 0.85

Analyzing partially missing confounder information in comparative effectiveness and safety research of therapeutics. Pharmacoepidemiol Drug Saf (2012) 0.85

Low-dose aspirin and upper gastrointestinal bleeding in primary versus secondary cardiovascular prevention: a population-based, nested case-control study. Circ Cardiovasc Qual Outcomes (2013) 0.84

Risk of complications after a peptic ulcer diagnosis: effectiveness of proton pump inhibitors. Dig Dis Sci (2013) 0.84

Prescription of antihypertensive medications during pregnancy in the UK. Pharmacoepidemiol Drug Saf (2014) 0.82

Gastroesophageal reflux disease in primary care: using changes in proton pump inhibitor therapy as an indicator of partial response. Scand J Gastroenterol (2012) 0.82

Risk factors for hyperkalaemia in a cohort of patients with newly diagnosed heart failure: a nested case-control study in UK general practice. Eur J Heart Fail (2015) 0.81

Risk factors for falls with use of acid-suppressive drugs. Epidemiology (2013) 0.81

Use of angiotensin II receptor blockers and the risk of acute pancreatitis: a nested case-control study. Pancreatology (2010) 0.81

Antibiotic use and the risk of lung cancer. Cancer Epidemiol Biomarkers Prev (2008) 0.80

Epidemiology of meningioma in the United Kingdom. Neuroepidemiology (2012) 0.80

Angiotensin-converting enzyme inhibitors and risk of esophageal and gastric cancer: a nested case-control study. Clin Gastroenterol Hepatol (2007) 0.80

Patterns in the use of low-dose acetylsalicylic acid and other therapies following upper gastrointestinal bleeding. Am J Cardiovasc Drugs (2014) 0.79

Effect of baseline gastrointestinal risk and use of proton pump inhibitors on frequency of discontinuation of aspirin for secondary cardiovascular prevention in United kingdom primary care. Am J Cardiol (2013) 0.78

Represcription of low-dose acetylsalicylic acid after discontinuation in patients receiving treatment for secondary cardiovascular disease prevention in the UK. Am J Cardiovasc Drugs (2014) 0.78

Follow-up of a cohort of children and adolescents with gastro-esophageal reflux disease who were free of reflux esophagitis at initial diagnosis. Scand J Gastroenterol (2010) 0.78

[Aspirin use in patients with diabetes mellitus]. Med Clin (Barc) (2004) 0.77

Challenges of using primary care electronic medical records in the UK to study medications in pregnancy. Pharmacoepidemiol Drug Saf (2013) 0.77

Treatment patterns in paediatric patients with a new diagnosis of gastroesophageal reflux disease. Eur J Gastroenterol Hepatol (2011) 0.76

Study of the association between hip fracture and acid-suppressive drug use in a UK primary care setting. Pharmacotherapy (2014) 0.76

The continuing unacceptable marketing of Alka-Seltzer containing aspirin for stomach-related disorders. Drug Saf (2009) 0.75

Predictors and time trends in clopidogrel and proton pump inhibitor coprescription with low-dose acetylsalicylic acid. Pharmacoepidemiol Drug Saf (2012) 0.75

Labor induction with dinoprostone or oxytocine and postpartum disseminated intravascular coagulation: a hospital-based case-control study. Am J Obstet Gynecol (2004) 0.75